Thema: |
|
||
Autor: | Phil Gates | ||
Datum: | 18.12.21 09:22 | ||
Antwort auf: | Neues zur U5-Impfung von Biontech von Cerberus | ||
>[https://www.timesofisrael.com/pfizer-testing-3rd-covid-vaccine-dose-for-kids-under-5-after-setback] > >"Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers instead of the usual two. > >The addition of an extra dose came after a preliminary analysis found 2- to 4-year-olds didn’t have as strong an immune response as expected to special low-dose shots. > >Pfizer had planned to release data from its study of children under 5 by the end of the year. It’s not clear how this change will delay the quest to vaccinate the youngest children. > >Pfizer and its partner BioNTech said if the three-dose study is successful, they plan to apply for emergency authorization sometime in the first half of 2022." Mist! |
|||
< antworten > | |||